Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapy
- PMID: 33426249
- PMCID: PMC7777455
- DOI: 10.1016/j.jdcr.2020.11.016
Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapy
Keywords: JAK inhibitor; JAK, Janus kinase; JAK-STAT; Janus kinase; PDL, pulsed dye laser; angiolupoid sarcoidosis; sarcoidosis; tofacitinib.
Conflict of interest statement
Dr King is an investigator for Concert Pharmaceuticals Inc, Eli Lilly and Company, and Pfizer Inc; is a consultant to and/or investigator for and/or has served on advisory boards for Aclaris Therapeutics, Arena Pharmaceuticals, Bristol-Meyers Squibb, Concert Pharmaceuticals Inc, Dermavant Sciences, Eli Lilly and Company, Pfizer Inc, and Viela Bio; and is on the speaker's bureau for Regeneron and Sanofi Genzyme. Dr Damsky has research funding from 10.13039/100004319Pfizer, is a consultant for Eli Lilly and Twi Biotechnology, and receives licensing fees from EMD/Sigma/Millipore in unrelated work. Authors Singh and Wang and Drs Heald, McNiff, Suozzi, and Leventhal have no conflicts of interest to declare.
Figures
![Fig 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7777455/bin/gr1.gif)
Similar articles
-
Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment.JAAD Case Rep. 2023 Jun 15;38:61-63. doi: 10.1016/j.jdcr.2023.06.006. eCollection 2023 Aug. JAAD Case Rep. 2023. PMID: 37600732 Free PMC article. No abstract available.
-
Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare.J Am Acad Dermatol. 2020 Mar;82(3):612-621. doi: 10.1016/j.jaad.2019.05.098. Epub 2019 Jun 8. J Am Acad Dermatol. 2020. PMID: 31185230 Free PMC article.
-
Treatment of cutaneous sarcoidosis with tofacitinib 2% ointment and extra virgin olive oil.JAAD Case Rep. 2020 Dec 25;9:1-3. doi: 10.1016/j.jdcr.2020.12.021. eCollection 2021 Mar. JAAD Case Rep. 2020. PMID: 33598514 Free PMC article. No abstract available.
-
Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn's disease.World J Gastroenterol. 2020 Jul 28;26(28):4055-4075. doi: 10.3748/wjg.v26.i28.4055. World J Gastroenterol. 2020. PMID: 32821070 Free PMC article. Review.
-
Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases.Pharmacol Res. 2016 Sep;111:784-803. doi: 10.1016/j.phrs.2016.07.038. Epub 2016 Jul 26. Pharmacol Res. 2016. PMID: 27473820 Review.
Cited by
-
Recent Clinical Studies on the Effects of Tumor Necrosis Factor-Alpha (TNF-α) and Janus Kinase/Signal Transducers and Activators of Transcription (JAK/STAT) Antibody Therapies in Refractory Cutaneous Sarcoidosis: A Systematic Review.Cureus. 2023 Sep 8;15(9):e44901. doi: 10.7759/cureus.44901. eCollection 2023 Sep. Cureus. 2023. PMID: 37818515 Free PMC article. Review.
-
Molecularly Targeted Therapies for Inflammatory Cutaneous Granulomatous Disorders: A Review of the Evidence and Implications for Understanding Disease Pathogenesis.JID Innov. 2023 Aug 10;3(5):100220. doi: 10.1016/j.xjidi.2023.100220. eCollection 2023 Sep. JID Innov. 2023. PMID: 37719661 Free PMC article. Review.
-
Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment.JAAD Case Rep. 2023 Jun 15;38:61-63. doi: 10.1016/j.jdcr.2023.06.006. eCollection 2023 Aug. JAAD Case Rep. 2023. PMID: 37600732 Free PMC article. No abstract available.
-
Ruxolitinib cream for the treatment of cutaneous sarcoidosis.JAAD Case Rep. 2023 Jun 3;38:111-112. doi: 10.1016/j.jdcr.2023.05.032. eCollection 2023 Aug. JAAD Case Rep. 2023. PMID: 37521191 Free PMC article. No abstract available.
-
Tofacitinib, a suppressor of NOD2 expression, is a potential treatment for Blau syndrome.Front Immunol. 2023 Jun 21;14:1211240. doi: 10.3389/fimmu.2023.1211240. eCollection 2023. Front Immunol. 2023. PMID: 37415984 Free PMC article.
References
-
- Noe M.H., Rosenbach M. Cutaneous sarcoidosis. Curr Opin Pulm Med. 2017;23(5):482–486. - PubMed
-
- Wu M.C., Lee J.Y. Cutaneous sarcoidosis in southern Taiwan: clinicopathologic study of a series with high proportions of lesions confined to the face and angiolupoid variant. J Eur Acad Dermatol Venereol. 2013;27(4):499–505. - PubMed
-
- Wanat K.A., Rosenbach M. A practical approach to cutaneous sarcoidosis. Am J Clin Dermatol. 2014;15(4):283–297. - PubMed
-
- Broos C.E., Hendriks R.W., Kool M. T-cell immunology in sarcoidosis: disruption of a delicate balance between helper and regulatory T-cells. Curr Opin Pulm Med. 2016;22(5):476–483. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources